In the process, GSH is oxidized to glutathione disulfide (GSSG), as observed in laboratory models
While the 2024 guidelines already recommended glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for weight loss due to their proven efficacy in reducing body weight and improving glycemic control, the 2025 update broadens their scope of use for their multifaceted benefits in diabetes management, including weight loss, kidney disease, and metabolic dysfunction-associated steatotic liver disease (MASLD)/metabolic-associated steatohepatitis (MASH) [11, 12]
muciniphila are still present with washed cells and after pasteurization, it is unlikely that SCFA signaling plays an important role
That matters because what helps most is seeing how your body responded across months, not only what happened this week
Theres a study de Sousa referenced that found the body can store a two to three year supply of B12 when excess amounts are injected